ESC 365 - State-of-the-art lecture in lipid lowering therapy and the atheroma .

ESC Professional Premium Access

State-of-the-art lecture in lipid lowering therapy and the atheroma .

Session: Lipid-lowering therapy and the atheroma

Topic: Pathophysiology and Mechanisms

Speaker: Professor S. Nicholls (Melbourne, AU)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Stephen Nicholls

Monash University, Melbourne (Australia)

53 presentations

5 followers

2 more presentations in this session

Longer-term safety of alirocumab with 24,610 patient-years of placebo-controlled observation: Further insights from the ODYSSEY OUTCOMES trial

Speaker: Doctor S. Goodman (Toronto, CA)

Interrelation between baseline plaque characteristics and changes in coronary atherosclerosis with the PCSK9-inhibitor alirocumab: Insights from the PACMAN-AMI randomized trial

Speaker: Doctor K. Koskinas (Bern, CH)

Access the full session

Lipid-lowering therapy and the atheroma

Speakers: Professor S. Nicholls, Doctor S. Goodman, Doctor K. Koskinas

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources